cytosolic phospholipase A2 inhibitors (Westfalian Wilhelms-University of Muenster/Provendis)

N/A

Report date: 2025/03/18 18:14:42
NME

Base Information

Drug Namecytosolic phospholipase A2 inhibitors (Westfalian Wilhelms-University of Muenster/Provendis)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCytosolic phospholipase A2 inhibitors
TargetsCytosolic phospholipase A2
Therapy Area/IndicationsInflammationImmune System DiseasesCommunicable Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesPROvendis GmbH
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsInflammationImmune System DiseasesCommunicable Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A